Invivo Partners participates in the €11.1 million Seed extension round of Signadori Bio alongside Taiho Ventures and Sofinnova Partners

by Invivo Capital

Signadori Bio focuses on directly engineering monocytes in vivo to reprogram myeloid anti-tumour activity, aiming to overcome the immunosuppressive tumour microenvironment and unlock a new class of of...

Read more

Invivo Partners Launches €100M InvivoAI Fund to Accelerate Deeptech and AI Innovation in Spain

by Invivo Capital

Invivo Ventures AI will target early-stage companies applying AI to advance biotechnology and other science-driven domains. The fund is designed to capitalize on the surging momentum in AI, with deal ...

Read more

CDTI invests in Integra Therapeutics, together with Invivo, Columbus, and AdBio Partners

by CDTI Innovación

Innvierte SICC of CDTI Innovación invests in Integra Therapeutics, together with three co-investors, to develop a gene-editing platform for the treatment of oncological, autoimmune, and genetic disea...

Read more

ARTHEx Biotech Upsizes Series B Financing Round to $87 millones

by Columbus Venture Partners

The Series B extension financing was led by Bpifrance and joined by all existing shareholders, including AdBio Partners, CDTI Innovación, Columbus Venture Partners, European Innovation Council (EIC),...

Read more

Invivo Partners joins Sofinnova Partners in Signadori Bio

by Invivo Capital

Signadori Bio is a preclinical-stage biopharmaceutical company developing an innovative cell therapy platform to transform cancer treatment. The company’s proprietary platform originates from Gustav...

Read more

Invivo Partners leads €20 million Series A round in Neumirna Therapeutics with Angelini Ventures

by Invivo Capital

Neumirna was founded with the mission to revolutionize the treatment paradigms for challenging neurological conditions, and is at the forefront of RNA therapeutics, harnessing the power of microRNAs (...

Read more

ICF invests €8M in life sciences through Invivo Ventures III fund

by Institut Català de Finances (ICF)

Taking advantage of a long history of collaboration, the Catalan Institute of Finance (ICF) once again invests in Invivo Partners. On this occasion, the public promotion bank of the Generalitat invest...

Read more

Invivo Partners is preparing to launch a €100M Invivo Ventures III Fund to invest in Leading-Edge Life Sciences

by Invivo Capital

Invivo Ventures III is strategically designed to propel the emergent field of synthetic biology, a domain where Invivo has already established a formidable presence through investments in pioneering c...

Read more

Invivo Ventures Invests in EsoBiotec to Revolutionize Cancer Cell Therapy with Cutting-Edge In Vivo Engineering Platform

by Invivo Capital

Invivo Ventures announces an investment of €2 million in EsoBiotec, a pioneering biotechnology company focused on developing in vivo engineered cell therapies for cancer treatment. This investment i...

Read more
Subscribe to Directory
Write an Article

Highlight

Axon moves into Cloud Technology

by Axon Partners Group

cloud technology axon

Xcalibur Smart Mapping strengthens its g...

by MCH Private Equity

​Xcalibur Smart Mapping, recognised as the global leader in airborne...

Photos Stream